Literature DB >> 17879214

Cystatin C as marker of residual renal function in patients on peritoneal dialysis: relation with parameters of peritoneal function.

Silvia Ros1, Auxiliadora Bajo, Gloria del Peso, Auxiliadora Garcia de Miguel, Soledad Santacruz, Ernesto Fernandez, Raquel de Garcia, Rafael Selgas.   

Abstract

INTRODUCTION: Cystatin C (CysC) is a nonglycosylated protein of low molecular weight not influenced by age, sex or inflammation. The aim of this paper is to ascertain the usefulness of serum CysC level determination in peritoneal dialysis (PD) patients.
MATERIAL AND METHODS: CysC serum levels were determined in 80 PD patients. The mean age of patients was 53.7 +/- 15 years, with 15.3 +/- 25.8 months on PD. Thirty-three percent were on continuous ambulatory peritoneal dialysis (CAPD) and 66.3% on automated peritoneal dialysis (APD). Fourteen patients (17%) had no residual renal function (RRF).
RESULTS: Mean CysC levels were 5.8 +/- 1.4 mg/L, without differences between men (5.5 +/- 1.4 mg/L) and women (5.6 +/- 1.5 mg/L, NS). There was no correlation between CysC levels and age, weight, height or time on PD. Anuric patients had CysC levels significantly higher than non-anuric (6.7 +/- 1.4 vs. 5.3 +/- 1.3 mg/L, p<0.001). CysC levels showed an inverse correlation with RRF (r=-0.60, p<0.001) and residual urine volume (r=-0.58, p<0.001).
CONCLUSIONS: In conclusion, serum CysC levels had the same statistical significance as plasma creatinine levels, and they are not influenced by peritoneal transport in PD patients. Consequently, both parameters are valid RRF markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879214

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

Review 1.  Residual renal function assessment with cystatin C.

Authors:  Guido Filler; Shih-Han S Huang; Robert M Lindsay
Journal:  Pediatr Nephrol       Date:  2010-11-07       Impact factor: 3.714

2.  Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis.

Authors:  Su Jin Kim; Young Bae Sohn; Sung Won Park; Dong-Kyu Jin; Kyung Hoon Paik
Journal:  Pediatr Nephrol       Date:  2010-11-11       Impact factor: 3.714

3.  Endogenous markers for estimation of renal function in peritoneal dialysis patients.

Authors:  Krista Dybtved Kjaergaard; Jens Dam Jensen; Michael Rehling; Bente Jespersen
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

4.  Serum β-trace protein and risk of mortality in incident hemodialysis patients.

Authors:  Tariq Shafi; Rulan S Parekh; Bernard G Jaar; Laura C Plantinga; Pooja C Oberai; John H Eckfeldt; Andrew S Levey; Neil R Powe; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-28       Impact factor: 8.237

Review 5.  Strategies for the preservation of residual renal function in pediatric dialysis patients.

Authors:  Melissa A Cadnapaphornchai; Isaac Teitelbaum
Journal:  Pediatr Nephrol       Date:  2013-07-19       Impact factor: 3.714

6.  EHS and AHS guidelines for treatment of primary ventral hernias in rare locations or special circumstances.

Authors:  N A Henriksen; R Kaufmann; M P Simons; F Berrevoet; B East; J Fischer; W Hope; D Klassen; R Lorenz; Y Renard; M A Garcia Urena; A Montgomery
Journal:  BJS Open       Date:  2020-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.